Rizatriptan Benzoate Orally Disintegrating Tablets 10mg recall: Impurity Out of Spec
Rizatriptan Benzoate Orally Disintegrating Tablets 10mg, 18 Tablets (3 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods…
Why was Rizatriptan Benzoate Orally Disintegrating Tablets 10mg recalled?
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: BRM2111A, BRM2112A, BRM2113A, BRM2114A, BRM2115A, BRM2116A, exp. date 04/2025
- Product
- Rizatriptan Benzoate Orally Disintegrating Tablets 10mg, 18 Tablets (3 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods…
- Recalling firm
- MACLEODS PHARMA USA, INC
- Quantity
- 643,800 Blister Packs /888,336 Tablets
- Distribution
- Nationwide within the United States
- Recall date
- November 3, 2021
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)